BIOMAT Database Logo BIOMAT Database Logo

Prophylaxis of the occurrence of hyperbilirubinemia in relation to maternal oxytocin infusion with steroid treatment. 1998

O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
Department of Obstetrics and Gynecology, Sutcu Imam University, Kahramanmaraş, Turkey.

This study was carried out to investigate the steroid prevention on the occurrence and the severity of red blood cell destruction by the effect of oxytocin usage for labor induction. Venous cord blood was collected from the pregnancies who had oxytocin-induced or augmented labors (20), oxytocin-infused deliveries with steroid use (20), deliveries without oxytocin use (20) and cesarean sections (20). Evaluation of the data showed significant increase in serum bilirubin level, serum lactic dehydrogenase activity, erythrocyte fragility and reticulocyte count (p < 0.0083), and a significant decrease in hemoglobulin concentration, packed red cell volume fraction (p < 0.01) in groups with labor induction or augmentation with oxytocin in comparison to deliveries with oxytocin plus steroid use and the two other methods of delivery. Moreover, with regard to the above data, no significant difference was observed between the deliveries other than oxytocin-only use. Mean corpuscular volume in the oxytocin group was apparently (not significant) higher than the steroid group. The results of this study suggest that the use of 16 mg dexamethasone 21-phosphate at the beginning of the induction or augmentation of labor with oxytocin, followed by an additional 4-mg dose 4 h later intravenously, is advantageous for the prevention of erythrocyte destruction.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007567 Jaundice, Neonatal Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES. Icterus Gravis Neonatorum,Neonatal Jaundice,Physiological Neonatal Jaundice,Severe Jaundice in Neonate,Severe Jaundice in Newborn,Jaundice, Physiological Neonatal,Neonatal Jaundice, Physiological
D007751 Labor, Induced Artificially induced UTERINE CONTRACTION. Induced Labor,Induction of Labor,Labor Induced,Labor Induction,Induced, Labor,Induction, Labor,Inductions, Labor,Labor Inductions
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D009996 Osmotic Fragility RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst. Saline Fragility,Fragility, Osmotic,Fragility, Saline
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002585 Cesarean Section Extraction of the FETUS by means of abdominal HYSTEROTOMY. Abdominal Delivery,Delivery, Abdominal,C-Section (OB),Caesarean Section,Postcesarean Section,Abdominal Deliveries,C Section (OB),C-Sections (OB),Caesarean Sections,Cesarean Sections,Deliveries, Abdominal
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004909 Erythrocyte Indices ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC). Erythrocyte Hemoglobin, Mean Cell,Erythrocyte Size Determination,Erythrocyte Volume, Mean Cell,Hemoglobin, Erythrocyte, Mean Cell,Mean Corpuscular Volume,Red Cell Indices,Erythrocyte Diameter,Erythrocyte Index,Erythrocyte Indexes,Erythrocyte Thickness,Mean Cell Hemoglobin Concentration,Mean Cell Volume,Mean Corpuscular Hemoglobin,Mean Corpuscular Hemoglobulin Concentration,Red Cell Distribution Width,Red Cell Index,Red Cell Indexes,Cell Volumes, Mean,Corpuscular Volumes, Mean,Determination, Erythrocyte Size,Determinations, Erythrocyte Size,Diameter, Erythrocyte,Diameters, Erythrocyte,Erythrocyte Diameters,Erythrocyte Size Determinations,Hemoglobin, Mean Corpuscular,Hemoglobins, Mean Corpuscular,Index, Erythrocyte,Index, Red Cell,Indexes, Erythrocyte,Indexes, Red Cell,Indices, Erythrocyte,Indices, Red Cell,Mean Cell Volumes,Mean Corpuscular Hemoglobins,Mean Corpuscular Volumes,Size Determination, Erythrocyte,Size Determinations, Erythrocyte,Thickness, Erythrocyte,Volume, Mean Cell,Volume, Mean Corpuscular,Volumes, Mean Cell,Volumes, Mean Corpuscular

Related Publications

O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
[Transitory hyperbilirubinemia and oxytocin infusion].
January 1978, Zentralblatt fur Gynakologie,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
[Oxytocin infusion and nonhemolytic neonatal hyperbilirubinemia].
January 1988, Akusherstvo i ginekologiia,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
Neonatal jaundice and maternal oxytocin infusion.
September 1973, British medical journal,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
[Planned delivery by oxytocin infusion in relation to cephalic dystocia].
May 1994, Zhonghua fu chan ke za zhi,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
Letter: Neonatal jaundice and maternal oxytocin infusion.
October 1973, British medical journal,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
Letter: Neonatal jaundice and maternal oxytocin infusion.
September 1973, British medical journal,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
The effect of labour and maternal oxytocin infusion on fetal plasma oxytocin concentration.
December 1999, British journal of obstetrics and gynaecology,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
[The role of oxytocin in neonatal hyperbilirubinemia].
October 1983, Minerva pediatrica,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
Prophylaxis of neonatal hyperbilirubinemia with phenobarbital.
July 1972, Obstetrics and gynecology,
O A Leylek, and A Ergur, and F Senocak, and M Sencan, and S Bakir, and H Ozdemir, and S Songur
Neonatal hyperbilirubinemia after treatment of maternal leprosy.
May 1989, Southern medical journal,
Copied contents to your clipboard!